Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326

1.

Clinical and molecular analyses of bloodstream infections caused by IMP metallo-β-lactamase-producing Enterobacteriaceae in a tertiary hospital in Japan.

Mori N, Kagawa N, Aoki K, Ishi Y, Tateda K, Aoki Y.

J Infect Chemother. 2019 Aug 16. pii: S1341-321X(19)30228-4. doi: 10.1016/j.jiac.2019.07.017. [Epub ahead of print]

PMID:
31427199
2.

JunB plays a crucial role in development of regulatory T cells by promoting IL-2 signaling.

Katagiri T, Yamazaki S, Fukui Y, Aoki K, Yagita H, Nishina T, Mikami T, Katagiri S, Shiraishi A, Kimura S, Tateda K, Sumimoto H, Endo S, Kameda H, Nakano H.

Mucosal Immunol. 2019 Jul 8. doi: 10.1038/s41385-019-0182-0. [Epub ahead of print]

PMID:
31285535
3.

Equol inhibits growth and spore formation of Clostridioides difficile.

Tanaka Y, Kimura S, Ishii Y, Tateda K.

J Appl Microbiol. 2019 Sep;127(3):932-940. doi: 10.1111/jam.14353. Epub 2019 Jun 18.

PMID:
31211883
4.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
5.

Morphological and Biological Characteristics of Staphylococcus aureus Biofilm Formed in the Presence of Plasma.

Sato A, Yamaguchi T, Hamada M, Ono D, Sonoda S, Oshiro T, Nagashima M, Kato K, Okazumi S, Katoh R, Ishii Y, Tateda K.

Microb Drug Resist. 2019 Jun;25(5):668-676. doi: 10.1089/mdr.2019.0068. Epub 2019 May 17.

6.

Left ventricular assist device-associated endocarditis involving multiple clones of Staphylococcus aureus with distinct antimicrobial susceptibility patterns.

Harada S, Aoki K, Okamoto K, Kinoshita O, Nawata K, Ishii Y, Tateda K, Sasaki M, Saga T, Doi Y, Yotsuyanagi H, Moriya K, Ono M.

Int J Infect Dis. 2019 Jul;84:44-47. doi: 10.1016/j.ijid.2019.05.001. Epub 2019 May 7.

7.

Emergence of IMP-producing hypervirulent Klebsiella pneumoniae carrying a pLVPK-like virulence plasmid.

Harada S, Aoki K, Ishii Y, Ohno Y, Nakamura A, Komatsu M, Tateda K.

Int J Antimicrob Agents. 2019 Jun;53(6):873-875. doi: 10.1016/j.ijantimicag.2019.05.007. Epub 2019 May 7. No abstract available.

PMID:
31075402
8.

Evolutionary and Genomic Insights into Clostridioides difficile Sequence Type 11: a Diverse Zoonotic and Antimicrobial-Resistant Lineage of Global One Health Importance.

Knight DR, Kullin B, Androga GO, Barbut F, Eckert C, Johnson S, Spigaglia P, Tateda K, Tsai PJ, Riley TV.

MBio. 2019 Apr 16;10(2). pii: e00446-19. doi: 10.1128/mBio.00446-19.

9.

Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: A longitudinal analysis from 1994 to 2016.

Tateda K, Ohno A, Ishii Y, Murakami H, Yamaguchi K; Levofloxacin surveillance group.

J Infect Chemother. 2019 Aug;25(8):594-604. doi: 10.1016/j.jiac.2019.03.008. Epub 2019 Apr 3.

10.

Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia.

Miyashita N, Horita N, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Ogasawara K, Kiyota H, Watanabe A.

J Infect Chemother. 2019 Jun;25(6):407-412. doi: 10.1016/j.jiac.2019.03.009. Epub 2019 Mar 29.

11.

Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.

Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Wada K, Kobayashi K, Hamasuna R, Minamitani S, Matsumoto T, Kiyota H, Tateda K, Sato J, Hanaki H, Masumori N, Nishiyama H, Miyazaki J, Fujimoto K, Tanaka K, Uehara S, Matsubara A, Ito K, Hayashi K, Kurimura Y, Ito S, Takeuchi T, Narita H, Izumitani M, Nishimura H, Kawahara M, Hara M, Hosobe T, Takashima K, Chokyu H, Matsumura M, Ihara H, Uno S, Monden K, Sumii T, Kawai S, Kariya S, Sato T, Yoshioka M, Kadena H, Matsushita S, Nishi S, Hosokawa Y, Shirane T, Yoh M, Watanabe S, Makinose S, Uemura T, Goto H.

J Infect Chemother. 2019 Jun;25(6):413-422. doi: 10.1016/j.jiac.2019.02.021. Epub 2019 Mar 21.

12.

Epidemiology and genotypic characterisation of dissemination patterns of uropathogenic Escherichia coli in a community.

Matsukawa M, Igarashi M, Watanabe H, Qin L, Ohnishi M, Terajima J, Iyoda S, Morita-Ishihara T, Tateda K, Ishii Y, Saga T, Aoki K, Bonomo RA.

Epidemiol Infect. 2019 Jan;147:e148. doi: 10.1017/S0950268819000426.

13.

Long-term observation of antimicrobial susceptibility and molecular characterisation of Campylobacter jejuni isolated in a Japanese general hospital 2000-2017.

Yamada K, Saito R, Muto S, Sasaki M, Murakami H, Aoki K, Ishii Y, Tateda K.

J Glob Antimicrob Resist. 2019 Feb 10;18:59-63. doi: 10.1016/j.jgar.2019.02.001. [Epub ahead of print]

PMID:
30753906
14.

Streptococcal toxic shock syndrome caused by β-hemolytic streptococci: Clinical features and cytokine and chemokine analyses of 15 cases.

Yoshizawa S, Matsumura T, Ikebe T, Ichibayashi R, Fukui Y, Satoh T, Tsubota T, Honda M, Ishii Y, Tateda K, Ato M.

J Infect Chemother. 2019 May;25(5):355-361. doi: 10.1016/j.jiac.2019.01.006. Epub 2019 Feb 7.

PMID:
30744988
15.

Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.

Ono D, Yamaguchi T, Hamada M, Sonoda S, Sato A, Aoki K, Kajiwara C, Kimura S, Fujisaki M, Tojo H, Sasaki M, Murakami H, Kato K, Ishii Y, Tateda K.

J Infect Chemother. 2019 Apr;25(4):273-280. doi: 10.1016/j.jiac.2018.12.007. Epub 2019 Jan 31.

PMID:
30713034
16.

Overlapping Roles for Interleukin-36 Cytokines in Protective Host Defense against Murine Legionella pneumophila Pneumonia.

Nanjo Y, Newstead MW, Aoyagi T, Zeng X, Takahashi K, Yu FS, Tateda K, Standiford TJ.

Infect Immun. 2018 Dec 19;87(1). pii: e00583-18. doi: 10.1128/IAI.00583-18. Print 2019 Jan.

17.

The palatine tonsil bacteriome, but not the mycobiome, is altered in HIV infection.

Fukui Y, Aoki K, Ishii Y, Tateda K.

BMC Microbiol. 2018 Oct 5;18(1):127. doi: 10.1186/s12866-018-1274-9.

18.

A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.

Hirayama S, Yasui K, Murakami H, Kosugi T, Sakamoto M, Hanai Y, Matsuo K, Miyazaki T, Ishii Y, Nishizawa K, Tateda K.

J Infect Chemother. 2018 Dec;24(12):949-953. doi: 10.1016/j.jiac.2018.08.001. Epub 2018 Sep 27.

PMID:
30268412
19.

Carbapenem-resistant Klebsiella pneumoniae in a Febrile Neutropenia Patient With Acute Myelogenous Leukemia After Hematopoietic Stem Cell Transplantation.

Asai S, Ohshima T, Iwashita H, Ishii Y, Aoki K, Minakawa Y, Machida S, Umezawa K, Tateda K, Miyachi H.

Infect Dis Clin Pract (Baltim Md). 2018 Sep;26(5):e38-e39. doi: 10.1097/IPC.0000000000000633. Epub 2018 Apr 21. No abstract available.

20.

Evidence of latent molecular diversity determining the virulence of community-associated MRSA USA300 clones in mice.

Sonoda S, Yamaguchi T, Aoki K, Ono D, Sato A, Kajiwara C, Kimura S, Akasaka Y, Ishii Y, Miyazaki Y, Inase N, Tateda K.

Immun Inflamm Dis. 2018 Sep;6(3):402-412. doi: 10.1002/iid3.234. Epub 2018 Aug 8.

21.

Role of interleukin-17 in a murine community-associated methicillin-resistant Staphylococcus aureus pneumonia model.

Shibue Y, Kimura S, Kajiwara C, Iwakura Y, Yamaguchi K, Tateda K.

Microbes Infect. 2019 Jan - Feb;21(1):33-39. doi: 10.1016/j.micinf.2018.06.006. Epub 2018 Jul 17.

PMID:
30026066
22.

Potential Role of Gr-1+ CD8+ T Lymphocytes as a Source of Interferon-γ and M1/M2 Polarization during the Acute Phase of Murine Legionella pneumophila Pneumonia.

Kusaka Y, Kajiwara C, Shimada S, Ishii Y, Miyazaki Y, Inase N, Standiford TJ, Tateda K.

J Innate Immun. 2018;10(4):328-338. doi: 10.1159/000490585. Epub 2018 Jul 18.

23.

Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.

Mikamo H, Tateda K, Yanagihara K, Kusachi S, Takesue Y, Miki T, Oizumi Y, Gamo K, Hashimoto A, Toyoshima J, Kato K.

J Infect Chemother. 2018 Sep;24(9):744-752. doi: 10.1016/j.jiac.2018.05.010. Epub 2018 Jun 19.

24.

Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty.

Nagoya S, Tateda K, Okazaki S, Kosukegawa I, Shimizu J, Yamashita T.

Eur J Orthop Surg Traumatol. 2018 Dec;28(8):1601-1607. doi: 10.1007/s00590-018-2223-x. Epub 2018 May 17.

PMID:
29774416
25.

Molecular epidemiology of Klebsiella pneumoniae K1 and K2 isolates in Japan.

Harada S, Ishii Y, Saga T, Aoki K, Tateda K.

Diagn Microbiol Infect Dis. 2018 Aug;91(4):354-359. doi: 10.1016/j.diagmicrobio.2018.03.010. Epub 2018 Mar 20.

PMID:
29678299
26.

Mupirocin at Subinhibitory Concentrations Induces Biofilm Formation in Staphylococcus aureus.

Sritharadol R, Hamada M, Kimura S, Ishii Y, Srichana T, Tateda K.

Microb Drug Resist. 2018 Nov;24(9):1249-1258. doi: 10.1089/mdr.2017.0290. Epub 2018 Mar 14.

PMID:
29653478
27.

[National Trends in the Distribution of Candida Species Causing Candidemia in Japan from 2003 to 2014].

Kakeya H, Yamada K, Kaneko Y, Yanagihara K, Tateda K, Maesaki S, Takesue Y, Tomono K, Kadota JI, Kaku M, Miyazaki Y, Kamei K, Shibuya K, Niki Y, Yoshida M, Sei Y.

Med Mycol J. 2018;59(1):E19-E22. doi: 10.3314/mmj.17-00014. Japanese.

28.

In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.

Miyashita N, Kobayashi I, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Ogasawara K, Kurachi S, Ishikawa T, Ishimura Y, Kanesaka I, Kiyota H, Watanabe A.

J Infect Chemother. 2018 May;24(5):325-329. doi: 10.1016/j.jiac.2018.01.018. Epub 2018 Feb 17.

PMID:
29459000
29.

Diagnostic predictors of Legionella pneumonia in Japan.

Miyashita N, Horita N, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Ogasawara K, Kiyota H, Watanabe A.

J Infect Chemother. 2018 Mar;24(3):159-163. doi: 10.1016/j.jiac.2017.12.009. Epub 2018 Feb 2. No abstract available.

PMID:
29398478
30.

Metagenomic analysis for detecting Fusarium solani in a case of fungal keratitis.

Shigeyasu C, Yamada M, Aoki K, Ishii Y, Tateda K, Yaguchi T, Okajima Y, Hori Y.

J Infect Chemother. 2018 Aug;24(8):664-668. doi: 10.1016/j.jiac.2017.12.019. Epub 2018 Jan 20.

PMID:
29371064
31.

Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo.

Aoki K, Harada S, Yahara K, Ishii Y, Motooka D, Nakamura S, Akeda Y, Iida T, Tomono K, Iwata S, Moriya K, Tateda K.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02091-17. doi: 10.1128/AAC.02091-17. Print 2018 Mar.

32.

Neonatal methicillin-resistant Staphylococcus aureus colonization and infection.

Shirai Y, Arai H, Tamaki K, Konishi H, Kawase Y, Shimizu N, Tateda K, Yoda H.

J Neonatal Perinatal Med. 2017;10(4):439-444. doi: 10.3233/NPM-16166.

PMID:
29286935
33.

Metformin Mediates Protection against Legionella Pneumonia through Activation of AMPK and Mitochondrial Reactive Oxygen Species.

Kajiwara C, Kusaka Y, Kimura S, Yamaguchi T, Nanjo Y, Ishii Y, Udono H, Standiford TJ, Tateda K.

J Immunol. 2018 Jan 15;200(2):623-631. doi: 10.4049/jimmunol.1700474. Epub 2017 Dec 15.

34.

Spread of mcr-1.5 in the community: an emerging threat.

Ishii Y, Aoki K, Endo S, Kiyota H, Aoyagi T, Kaku M, Bonomo RA, Tateda K.

Int J Antimicrob Agents. 2018 Jan;51(1):161-162. doi: 10.1016/j.ijantimicag.2017.10.015. Epub 2017 Nov 7. No abstract available.

PMID:
29127048
35.

Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation.

Someya K, Nakatsukasa H, Ito M, Kondo T, Tateda KI, Akanuma T, Koya I, Sanosaka T, Kohyama J, Tsukada YI, Takamura-Enya T, Yoshimura A.

Int Immunol. 2017 Aug 1;29(8):365-375. doi: 10.1093/intimm/dxx049.

36.

Clinical presentation of Legionella pneumonia: Evaluation of clinical scoring systems and therapeutic efficacy.

Miyashita N, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Ogasawara K, Kiyota H, Watanabe A.

J Infect Chemother. 2017 Nov;23(11):727-732. doi: 10.1016/j.jiac.2017.09.001. Epub 2017 Sep 23.

PMID:
28951197
37.

Administration of colistin sulfate in endotoxic model at slow and sustained fashion may reverse shock without causing nephrotoxicity in its optimal concentration.

Haque A, Ishii Y, Akasaka Y, Matsumoto T, Tateda K.

J Glob Antimicrob Resist. 2017 Dec;11:40-44. doi: 10.1016/j.jgar.2017.07.014. Epub 2017 Jul 31.

PMID:
28774864
38.

Public health and healthcare-associated risk of electric, warm-water bidet toilets.

Kanayama Katsuse A, Takahashi H, Yoshizawa S, Tateda K, Nakanishi Y, Kaneko A, Kobayashi I.

J Hosp Infect. 2017 Nov;97(3):296-300. doi: 10.1016/j.jhin.2017.07.021. Epub 2017 Jul 26.

PMID:
28756169
39.

Multicenter collaboration study on the β-lactam resistant Enterobacteriaceae in Japan - The 65th anniversary public interest purpose project of the Japanese Society of Chemotherapy.

Ishii Y, Aoki K, Tateda K, Kiyota H.

J Infect Chemother. 2017 Sep;23(9):583-586. doi: 10.1016/j.jiac.2017.06.009. Epub 2017 Jul 11.

PMID:
28709901
40.

Three-dimensional orientation of the acetabulum.

Suzuki D, Nagoya S, Takashima H, Tateda K, Yamashita T.

Clin Anat. 2017 Sep;30(6):753-760. doi: 10.1002/ca.22945. Epub 2017 Jul 6.

PMID:
28631289
41.

Azithromycin Modulates 3',5'-cyclic Diguanylic Acid Signaling in Pseudomonas aeruginosa.

Kimura S, Mori N, Kai T, Ishii Y, Yamaguchi K, Tateda K.

J Infect Chemother. 2017 Aug;23(8):550-555. doi: 10.1016/j.jiac.2017.05.002. Epub 2017 Jun 1.

PMID:
28579350
42.

Simple Screening for Carbapenemase-Producing Enterobacteriaceae by Moxalactam Susceptibility Testing.

Imai W, Sasaki M, Aoki K, Ishii Y, Bonomo RA, Koh TH, Murakami H, Morita T, Tateda K.

J Clin Microbiol. 2017 Jul;55(7):2276-2279. doi: 10.1128/JCM.00606-17. Epub 2017 May 3. No abstract available.

43.

Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society].

Tokuda H, Harigai M, Kameda H, Tomono K, Takayanagi N, Watanabe A, Tasaka S, Suda T, Tateda K, Kadota J.

Respir Investig. 2017 May;55(3):229-251. doi: 10.1016/j.resinv.2017.01.002. Epub 2017 Mar 29. Review. No abstract available.

PMID:
28427750
44.

Staphylococcus aureus surface contamination of mobile phones and presence of genetically identical strains on the hands of nursing personnel.

Katsuse Kanayama A, Takahashi H, Yoshizawa S, Tateda K, Kaneko A, Kobayashi I.

Am J Infect Control. 2017 Aug 1;45(8):929-931. doi: 10.1016/j.ajic.2017.02.011. Epub 2017 Apr 11.

PMID:
28410827
45.

Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Urabe N, Sakamoto S, Sano G, Suzuki J, Hebisawa A, Nakamura Y, Koyama K, Ishii Y, Tateda K, Homma S.

J Clin Microbiol. 2017 Jun;55(6):1738-1746. doi: 10.1128/JCM.02497-16. Epub 2017 Mar 22.

46.

Molecular epidemiological analysis of human- and chicken-derived isolates of Campylobacter jejuni in Japan using next-generation sequencing.

Ohishi T, Aoki K, Ishii Y, Usui M, Tamura Y, Kawanishi M, Ohnishi K, Tateda K.

J Infect Chemother. 2017 Mar;23(3):165-172. doi: 10.1016/j.jiac.2016.11.011. Epub 2017 Jan 10.

PMID:
28087306
47.

New possible biomarkers for diagnosis of infections and diagnostic distinction between bacterial and viral infections in children.

Yusa T, Tateda K, Ohara A, Miyazaki S.

J Infect Chemother. 2017 Feb;23(2):96-100. doi: 10.1016/j.jiac.2016.11.002. Epub 2016 Nov 25.

48.

Characterization and evaluation of a novel immunochromatographic assay for pharyngeal Mycoplasmapneumoniae ribosomal protein L7/L12 antigens.

Sano G, Itagaki T, Ishiwada N, Matsubara K, Iwata S, Nakamori Y, Matsuyama K, Watanabe K, Ishii Y, Homma S, Tateda K.

J Med Microbiol. 2016 Oct;65(10):1105-1110. doi: 10.1099/jmm.0.000336. Epub 2016 Aug 19.

PMID:
27542383
49.

Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia.

Yoshioka D, Kajiwara C, Ishii Y, Umeki K, Hiramatsu K, Kadota J, Tateda K.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6146-54. doi: 10.1128/AAC.01024-16. Print 2016 Oct.

50.

Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial - CORRIGENDUM.

Shinkai S, Toba M, Saito T, Sato I, Tsubouchi M, Taira K, Kakumoto K, Inamatsu T, Yoshida H, Fujiwara Y, Fukaya T, Matsumoto T, Tateda K, Yamaguchi K, Kohda N, Kohno S.

Br J Nutr. 2016 Sep;116(6):1138-40. doi: 10.1017/S0007114516002889. Epub 2016 Jul 29. No abstract available.

PMID:
27470085

Supplemental Content

Loading ...
Support Center